{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:04:54Z","timestamp":1754193894128},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T00:00:00Z","timestamp":1442275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138349","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T17:50:15Z","timestamp":1442339415000},"page":"e0138349","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enhanced Tuberculosis Infection Treatment Outcomes after Implementation of QuantiFERON\u00ae-Gold Testing"],"prefix":"10.1371","volume":"10","author":[{"given":"Aldo","family":"Crossa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany G.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"key":"ref1","author":"J Shabaro","year":"2006"},{"key":"ref2","first-page":"1","article-title":"Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America","volume":"54","author":"Z Taylor","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"K Lonnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1164\/rccm.200701-057OC","article-title":"Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999\u20132000","volume":"177","author":"DE Bennett","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5588\/ijtld.14.0373","article-title":"Latent tuberculous infection in the United States and Canada: who completes treatment and why?","volume":"19","author":"Y Hirsch-Moverman","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref6","first-page":"S384","article-title":"Tuberculosis contact investigations: outcomes in selected areas of the United States, 1999","volume":"7","author":"J Jereb","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1378\/chest.130.6.1712","article-title":"Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin","volume":"130","author":"A Lardizabal","year":"2006","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"NA Martinson","year":"2011","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"TR Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ebch.1962","article-title":"Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB","volume":"9","author":"SK Sharma","year":"2014","journal-title":"Evid Based Child Health"},{"key":"ref11","first-page":"1352","article-title":"Preventive chemotherapy. Where has it got us? Where to go next?","volume":"12","author":"J Landry","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref12","first-page":"1235","article-title":"Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada","volume":"12","author":"Y Hirsch-Moverman","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref13","first-page":"1443","article-title":"Physician attitudes regarding bacille Calmette-Guerin vaccination and treatment of latent tuberculosis infection","volume":"8","author":"J Salazar-Schicchi","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"U Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/593965","article-title":"Does the implementation of an interferon-gamma release assay in lieu of a tuberculin skin test increase acceptance of preventive therapy for latent tuberculosis among healthcare workers?","volume":"30","author":"R Sahni","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.5588\/ijtld.11.0102","article-title":"Programmatic impact of using QuantiFERON(R)-TB Gold in routine contact investigation activities","volume":"15","author":"JA Grinsdale","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e36551","DOI":"10.1371\/journal.pone.0036551","article-title":"Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic","volume":"7","author":"M Shah","year":"2012","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.5588\/ijtld.11.0017","article-title":"Indeterminate QuantiFERON(R)-TB Gold results in a public health clinic setting","volume":"15","author":"DB Banach","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref19","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"GH Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"ref20","article-title":"(In-Tube method) [package insert]","author":"Quantiferon-TB Gold","year":"2007","journal-title":"Cellestis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.161.4.16141","article-title":"Diagnostic Standards and Classification of Tuberculosis in Adults and Children","volume":"161","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref22","article-title":"Clinical Policies and Protocols","year":"2008"},{"key":"ref23","article-title":"Clinical Policies and Protocols","year":"1999"},{"key":"ref24","article-title":"City Health Information","year":"2000"},{"key":"ref25","article-title":"City Health Information","year":"2006"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jinf.2007.02.004","article-title":"QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants","volume":"55","author":"AC Carvalho","year":"2007","journal-title":"J Infect"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-3062.2009.00469.x","article-title":"Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients","volume":"12","author":"EC Seyhan","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/595695","article-title":"Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection","volume":"30","author":"P Vinton","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","article-title":"Latent TB infection treatment acceptance and completion in the United States and Canada","volume":"137","author":"CR Horsburgh Jr.","year":"2010","journal-title":"Chest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1016\/j.ijid.2009.05.007","article-title":"Adherence to treatment of latent tuberculosis infection in a clinical population in New York City","volume":"14","author":"J Li","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/1471-2458-12-468","article-title":"Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study","volume":"12","author":"ND Goswami","year":"2012","journal-title":"BMC Public Health"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e48900","DOI":"10.1371\/journal.pone.0048900","article-title":"Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic","volume":"7","author":"CC Dobler","year":"2012","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"A Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/thx.2009.119677","article-title":"Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries","volume":"65","author":"AB Hardy","year":"2010","journal-title":"Thorax"},{"key":"ref35","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"S Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ypmed.2003.11.012","article-title":"Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review","volume":"38","author":"MC Katapodi","year":"2004","journal-title":"Prev Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1345\/aph.1K209","article-title":"Factors related to adherence to statin therapy","volume":"41","author":"B McGinnis","year":"2007","journal-title":"Ann Pharmacother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s00198-009-1141-5","article-title":"Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures","volume":"21","author":"JT Schousboe","year":"2010","journal-title":"Osteoporos Int"},{"key":"ref39","first-page":"1650","article-title":"Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T15:58:43Z","timestamp":1567180723000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138349"}},"subtitle":[],"editor":[{"given":"Jean Louis","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,15]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138349","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,15]]}}}